JPWO2024029242A1 - - Google Patents

Info

Publication number
JPWO2024029242A1
JPWO2024029242A1 JP2024538862A JP2024538862A JPWO2024029242A1 JP WO2024029242 A1 JPWO2024029242 A1 JP WO2024029242A1 JP 2024538862 A JP2024538862 A JP 2024538862A JP 2024538862 A JP2024538862 A JP 2024538862A JP WO2024029242 A1 JPWO2024029242 A1 JP WO2024029242A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2024538862A
Other languages
Japanese (ja)
Other versions
JP7665261B2 (ja
JPWO2024029242A5 (cg-RX-API-DMAC7.html
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2024029242A1 publication Critical patent/JPWO2024029242A1/ja
Publication of JPWO2024029242A5 publication Critical patent/JPWO2024029242A5/ja
Priority to JP2025061336A priority Critical patent/JP2025102922A/ja
Application granted granted Critical
Publication of JP7665261B2 publication Critical patent/JP7665261B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2024538862A 2022-08-05 2023-06-29 新規lrp1結合ペプチド Active JP7665261B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025061336A JP2025102922A (ja) 2022-08-05 2025-04-02 新規lrp1結合ペプチド

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2022125238 2022-08-05
JP2022125238 2022-08-05
PCT/JP2023/024137 WO2024029242A1 (ja) 2022-08-05 2023-06-29 新規lrp1結合ペプチド

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025061336A Division JP2025102922A (ja) 2022-08-05 2025-04-02 新規lrp1結合ペプチド

Publications (3)

Publication Number Publication Date
JPWO2024029242A1 true JPWO2024029242A1 (cg-RX-API-DMAC7.html) 2024-02-08
JPWO2024029242A5 JPWO2024029242A5 (cg-RX-API-DMAC7.html) 2024-10-08
JP7665261B2 JP7665261B2 (ja) 2025-04-21

Family

ID=89848802

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2024538862A Active JP7665261B2 (ja) 2022-08-05 2023-06-29 新規lrp1結合ペプチド
JP2025061336A Pending JP2025102922A (ja) 2022-08-05 2025-04-02 新規lrp1結合ペプチド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025061336A Pending JP2025102922A (ja) 2022-08-05 2025-04-02 新規lrp1結合ペプチド

Country Status (4)

Country Link
EP (1) EP4541891A1 (cg-RX-API-DMAC7.html)
JP (2) JP7665261B2 (cg-RX-API-DMAC7.html)
CN (1) CN119630790A (cg-RX-API-DMAC7.html)
WO (1) WO2024029242A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025142861A1 (ja) * 2023-12-28 2025-07-03 一丸ファルコス株式会社 組成物

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015526434A (ja) * 2012-08-14 2015-09-10 アンジオケム インコーポレーテッド ペプチド−デンドリマーコンジュゲート及びその使用
JP2022033027A (ja) * 2020-08-11 2022-02-25 アプライド マテリアルズ イスラエル リミテッド ウエハ分析のための較正データを生成する方法およびシステム

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7110800B2 (ja) 2018-07-31 2022-08-02 株式会社三洋物産 遊技機
CA3128035A1 (en) * 2020-08-13 2022-02-13 Bioasis Technologies, Inc. Combination therapies for delivery across the blood brain barrier

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015526434A (ja) * 2012-08-14 2015-09-10 アンジオケム インコーポレーテッド ペプチド−デンドリマーコンジュゲート及びその使用
JP2022033027A (ja) * 2020-08-11 2022-02-25 アプライド マテリアルズ イスラエル リミテッド ウエハ分析のための較正データを生成する方法およびシステム

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ANDRE SEVERINE ET AL.: "Development of an LDL Receptor-Targeted Peptide Susceptible to Facilitate the Brain Access of Diagno", BIOLOGY, vol. 9, JPN6023037283, 2020, pages 161, ISSN: 0005459554 *
RUAN HUITONG ET AL.: "Stapled RAP12 peptide ligand of LRP1 for micelles-based multifunctional glioma-targeted drug deliver", CHEMICAL ENGINEERING JOURNAL, vol. 403, JPN6023037284, 2021, pages 126296, ISSN: 0005459553 *
SAKAMOTO KOTARO: "Generation of KS-487 as a novel LRP1-binding cyclic peptide with higher affinity, higher stability a", BIOCHEMISTRY AND BIOPHYSICS REPORTS, vol. 32, JPN6023037282, 8 October 2022 (2022-10-08), pages 101367, ISSN: 0005459555 *

Also Published As

Publication number Publication date
JP7665261B2 (ja) 2025-04-21
WO2024029242A1 (ja) 2024-02-08
JP2025102922A (ja) 2025-07-08
EP4541891A1 (en) 2025-04-23
CN119630790A (zh) 2025-03-14

Similar Documents

Publication Publication Date Title
BR102023005164A2 (cg-RX-API-DMAC7.html)
BR102022025291A2 (cg-RX-API-DMAC7.html)
BR102022017795A2 (cg-RX-API-DMAC7.html)
BR112025020304B1 (pt) Liga de solda, esfera de solda, pré-forma de solda, junta de solda e circuito
BR112025024041B1 (pt) Elemento de despejamento para uma embalagem compósita e embalagem compósita com um elemento de despejamento
BR112025008516B1 (pt) Método tudo em um de recuperação de níquel para recuperar níquel a partir de matérias-primas contendo níquel
BR112025016688B1 (pt) Compostos e composições farmacêuticas
BR112025011041B1 (pt) Dispositivo para inspeção de um elemento roscado e método de inspeção correspondente
BR112025005915B1 (pt) Gerador, dispositivo e método de ablação de campo pulsado
BR112025005363B1 (pt) Equipamento de usuário, entidade de rede e métodos relacionados
BR102023016405B1 (pt) Estrutura de viga de pá, pá de energia eólica e equipamento de energia eólica
BR112024025233B1 (pt) Método para alterar o estado de elevação vertical para um veículo transportador, controle e veículo
BR102023009702B1 (pt) Dispositivo para alisamento e aplicação de substância de tratamento
BR112024019620B1 (pt) Derivados de 2-[(2-oxo-4-fenil-2h-cromen-7-il)óxi]propanamido, composições farmacêuticas e usos
BR112024027500B1 (pt) Polipeptídeo, ácido nucleico, vetor, célula hospedeira, método para produzir o polipeptídeo, composição, uso do polipeptídeo, e, método para promover a proliferação de uma célula in vitro
BR102023002997B1 (pt) Um aparelho para detecção de vazamento de um gás e um método e um sistema do mesmo
BR112024018530B1 (pt) Método para determinar nível de escória do alto-forno, método para operar alto-forno e unidade de controle
BR112024027130B1 (pt) Sistema e método para um conjunto de cuff (balão) de tubo endotraqueal
BR112025001284B1 (pt) Cabo, sistema de sensor e método de montagem de um alojamento de sensor
BR102022024748B1 (pt) Equipamento extrator de esporos da superfície de grãos de cereal para aplicação em laboratório e seu processo operacional
BR102022023712B1 (pt) Sistema de montagem de estrutura flexível para estufas agrícolas, com sistema molejante de movimentação em relação à ação dos ventos
BR122025008970A2 (pt) Método para decodificar um vídeo, sistema e mídia legível por computador
BR122025008973A2 (pt) Sistema, método para decodificar um vídeo e mídia legível por computador
BR122025008972A2 (pt) Sistema, método para decodificar um vídeo e mídia legível por computador
BR102022012728B1 (pt) Unidade para visualização do reinício de escoamento de fluidos dependentes do tempo

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240724

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240724

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20240724

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20241112

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20241219

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250304

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250402

R150 Certificate of patent or registration of utility model

Ref document number: 7665261

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150